Framingham Company’s Study Provides Biological Insights Into The Increased Incidence Of COVID-19 In The African American Population
FRAMINGHAM – BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, yesterday, Se